Found: 14
Select item for more details and to access through your institution.
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet's Syndrome.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 809, doi. 10.1007/s40257-023-00783-7
- By:
- Publication type:
- Article
The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences.
- Published in:
- Schizophrenia Bulletin, 2008, v. 34, n. 1, p. 155
- By:
- Publication type:
- Article
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prescribing patterns of duloxetine in France: a prescription assessment study in real-world conditions.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2014, v. 52, n. 1, p. 1, doi. 10.5414/CP201894
- By:
- Publication type:
- Article
Función del cerebelo en la esquizofrenia: actualización de los indicios clínicos, cognitivos y funcionales.
- Published in:
- Schizophrenia Bulletin - Edición Española, 2009, v. 4, n. 1, p. 17, doi. 10.1093/schbul/sbm049
- By:
- Publication type:
- Article
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 33, doi. 10.1177/0333102420970889
- By:
- Publication type:
- Article
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 9, p. 2026, doi. 10.1111/head.13929
- By:
- Publication type:
- Article
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 348, doi. 10.1111/jdv.18689
- By:
- Publication type:
- Article
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0923-6
- By:
- Publication type:
- Article
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01292-w
- By:
- Publication type:
- Article
Efficacy and safety of erenumab in women with a history of menstrual migraine.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01167-6
- By:
- Publication type:
- Article